MAP3K20-AS1

Across TCGA pan-cancer cohorts, MAP3K20-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MAP3K20-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MAP3K20-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MAP3K20-AS1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and PAAD show a favorable association.

ACC, KIRC, and UVM are the cancer types where MAP3K20-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.637	0.943	<.001	153	view →
KIRC	DFS	Median	All	0.509	0.701	<.001	149	view →
UVM	DFS	Tertile	II,III,IV	0.288	0.797	<.001	90	view →
MESO	OS	Median	All	0.277	0.492	<.001	76	view →
LGG	OS	Median	All	0.734	0.878	<.001	44	view →
BLCA	OS	Tertile	II,III,IV	0.384	0.547	.008	40	view →
ESCA	DFS	Median	III,IV	0.584	0.284	<.001	39	view →
UCS	DFS	Median	All	0.178	0.391	.013	38	view →
LUAD	DFS	Quartile	All	0.730	0.867	.001	24	view →
DLBC	DFS	Median	All	0.332	0.858	.004	22	view →
SKCM	DFS	Quartile	III,IV	0.485	0.699	.006	10	view →
KIRP	DFS	Tertile	All	0.769	0.898	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

MAP3K20-AS1–ACC (OS)

Open the ACC breakdown →